GO.ID	term	definition	Oral_elim.genes_frequency	Oral_elim.pvalue	Oral_elim.-log10_pvalue	Oral_elim.Significant_genes	Oral_elim.Significant_genes_symbol
"GO:0033010"	"paranodal junction"	"A highly specialized cell-cell junction found in vertebrates, which forms between a neuron and a glial cell, and has structural similarity to Drosophila septate junctions. It flanks the node of Ranvier in myelinated nerve and electrically isolates the myelinated from unmyelinated nerve segments and physically separates the voltage-gated sodium channels at the node from the cluster of potassium channels underneath the myelin sheath."	"40% (4/10)"	0.004126014	2.38	"Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g30836.t1;Pocillopora_acuta_HIv2___TS.g18947.t1"	"Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)"
"GO:0005576"	"extracellular region"	"The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite."	"10.345% (129/1247)"	1.449671e-05	4.84	"Pocillopora_acuta_HIv2___RNAseq.22067_t;Pocillopora_acuta_HIv2___RNAseq.6093_tb;Pocillopora_acuta_HIv2___RNAseq.6257_t;Pocillopora_acuta_HIv2___RNAseq.g10475.t1;Pocillopora_acuta_HIv2___RNAseq.g10991.t1;Pocillopora_acuta_HIv2___RNAseq.g11410.t1;Pocillopora_acuta_HIv2___RNAseq.g11580.t1;Pocillopora_acuta_HIv2___RNAseq.g11588.t1;Pocillopora_acuta_HIv2___RNAseq.g12.t1;Pocillopora_acuta_HIv2___RNAseq.g12215.t1;Pocillopora_acuta_HIv2___RNAseq.g12286.t1;Pocillopora_acuta_HIv2___RNAseq.g12290.t1;Pocillopora_acuta_HIv2___RNAseq.g12292.t1;Pocillopora_acuta_HIv2___RNAseq.g12752.t1;Pocillopora_acuta_HIv2___RNAseq.g13.t1;Pocillopora_acuta_HIv2___RNAseq.g13044.t1;Pocillopora_acuta_HIv2___RNAseq.g13338.t1;Pocillopora_acuta_HIv2___RNAseq.g13339.t1;Pocillopora_acuta_HIv2___RNAseq.g13576.t1;Pocillopora_acuta_HIv2___RNAseq.g13977.t1;Pocillopora_acuta_HIv2___RNAseq.g14330.t3;Pocillopora_acuta_HIv2___RNAseq.g14336.t1;Pocillopora_acuta_HIv2___RNAseq.g14337.t1;Pocillopora_acuta_HIv2___RNAseq.g14348.t1;Pocillopora_acuta_HIv2___RNAseq.g15036.t2;Pocillopora_acuta_HIv2___RNAseq.g1508.t1;Pocillopora_acuta_HIv2___RNAseq.g1510.t1;Pocillopora_acuta_HIv2___RNAseq.g15370.t1;Pocillopora_acuta_HIv2___RNAseq.g15577.t1;Pocillopora_acuta_HIv2___RNAseq.g15584.t1;Pocillopora_acuta_HIv2___RNAseq.g15838.t1;Pocillopora_acuta_HIv2___RNAseq.g16095.t1;Pocillopora_acuta_HIv2___RNAseq.g16486.t1;Pocillopora_acuta_HIv2___RNAseq.g16699.t1;Pocillopora_acuta_HIv2___RNAseq.g17085.t1;Pocillopora_acuta_HIv2___RNAseq.g17089.t1;Pocillopora_acuta_HIv2___RNAseq.g17090.t1;Pocillopora_acuta_HIv2___RNAseq.g18123.t1;Pocillopora_acuta_HIv2___RNAseq.g18214.t1;Pocillopora_acuta_HIv2___RNAseq.g19312.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g20232.t1;Pocillopora_acuta_HIv2___RNAseq.g20413.t2;Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g20712.t1;Pocillopora_acuta_HIv2___RNAseq.g20860.t1;Pocillopora_acuta_HIv2___RNAseq.g21476.t1;Pocillopora_acuta_HIv2___RNAseq.g21627.t1;Pocillopora_acuta_HIv2___RNAseq.g21637.t1;Pocillopora_acuta_HIv2___RNAseq.g2185.t1b;Pocillopora_acuta_HIv2___RNAseq.g21957.t1;Pocillopora_acuta_HIv2___RNAseq.g22120.t1;Pocillopora_acuta_HIv2___RNAseq.g22283.t1;Pocillopora_acuta_HIv2___RNAseq.g23049.t1;Pocillopora_acuta_HIv2___RNAseq.g24120.t1;Pocillopora_acuta_HIv2___RNAseq.g25003.t1;Pocillopora_acuta_HIv2___RNAseq.g25458.t1;Pocillopora_acuta_HIv2___RNAseq.g25934.t1;Pocillopora_acuta_HIv2___RNAseq.g26596.t1;Pocillopora_acuta_HIv2___RNAseq.g26608.t1;Pocillopora_acuta_HIv2___RNAseq.g26701.t1;Pocillopora_acuta_HIv2___RNAseq.g26782.t1;Pocillopora_acuta_HIv2___RNAseq.g26783.t1;Pocillopora_acuta_HIv2___RNAseq.g27399.t1;Pocillopora_acuta_HIv2___RNAseq.g28025.t1;Pocillopora_acuta_HIv2___RNAseq.g28227.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28742.t1;Pocillopora_acuta_HIv2___RNAseq.g28858.t1;Pocillopora_acuta_HIv2___RNAseq.g29115.t1;Pocillopora_acuta_HIv2___RNAseq.g29841.t1;Pocillopora_acuta_HIv2___RNAseq.g29984.t1;Pocillopora_acuta_HIv2___RNAseq.g30425.t2;Pocillopora_acuta_HIv2___RNAseq.g31286.t1c;Pocillopora_acuta_HIv2___RNAseq.g3222.t1;Pocillopora_acuta_HIv2___RNAseq.g3624.t1;Pocillopora_acuta_HIv2___RNAseq.g3724.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___RNAseq.g4399.t2;Pocillopora_acuta_HIv2___RNAseq.g4770.t1;Pocillopora_acuta_HIv2___RNAseq.g4879.t1;Pocillopora_acuta_HIv2___RNAseq.g4954.t1;Pocillopora_acuta_HIv2___RNAseq.g584.t3a;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g687.t1;Pocillopora_acuta_HIv2___RNAseq.g7107.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1;Pocillopora_acuta_HIv2___RNAseq.g7443.t1;Pocillopora_acuta_HIv2___RNAseq.g7553.t1;Pocillopora_acuta_HIv2___RNAseq.g7667.t1;Pocillopora_acuta_HIv2___RNAseq.g7692.t1;Pocillopora_acuta_HIv2___RNAseq.g8217.t1;Pocillopora_acuta_HIv2___RNAseq.g8520.t1;Pocillopora_acuta_HIv2___RNAseq.g8913.t1;Pocillopora_acuta_HIv2___RNAseq.g8915.t1;Pocillopora_acuta_HIv2___RNAseq.g9027.t1;Pocillopora_acuta_HIv2___RNAseq.g9631.t1;Pocillopora_acuta_HIv2___RNAseq.g993.t1;Pocillopora_acuta_HIv2___RNAseq.g994.t1;Pocillopora_acuta_HIv2___TS.g13342.t1;Pocillopora_acuta_HIv2___TS.g1731.t1;Pocillopora_acuta_HIv2___TS.g17699.t2;Pocillopora_acuta_HIv2___TS.g19499.t2;Pocillopora_acuta_HIv2___TS.g19790.t1;Pocillopora_acuta_HIv2___TS.g20007.t1;Pocillopora_acuta_HIv2___TS.g201.t2;Pocillopora_acuta_HIv2___TS.g20880.t1;Pocillopora_acuta_HIv2___TS.g21857.t1;Pocillopora_acuta_HIv2___TS.g23115.t1;Pocillopora_acuta_HIv2___TS.g23175.t1;Pocillopora_acuta_HIv2___TS.g24662.t1;Pocillopora_acuta_HIv2___TS.g24807.t1;Pocillopora_acuta_HIv2___TS.g25258.t1;Pocillopora_acuta_HIv2___TS.g25259.t2;Pocillopora_acuta_HIv2___TS.g25792.t1c;Pocillopora_acuta_HIv2___TS.g27642.t1b;Pocillopora_acuta_HIv2___TS.g29407.t1;Pocillopora_acuta_HIv2___TS.g29618.t1;Pocillopora_acuta_HIv2___TS.g29621.t1;Pocillopora_acuta_HIv2___TS.g3256.t1;Pocillopora_acuta_HIv2___TS.g4148.t1c;Pocillopora_acuta_HIv2___TS.g5148.t1;Pocillopora_acuta_HIv2___TS.g8089.t1;Pocillopora_acuta_HIv2___TS.g8275.t1;Pocillopora_acuta_HIv2___TS.g9414.t1;Pocillopora_acuta_HIv2___TS.g9749.t1;Pocillopora_acuta_HIv2___TS.g9752.t3"	"Protein Wnt-2b;Multiple coagulation factor deficiency protein 2 homolog (Neural stem cell-derived neuronal survival protein);Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Myoferlin (Fer-1-like protein 3);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);Sperm-associated antigen 17 (Projection protein PF6 homolog);Hemicentin-1 (Fibulin-6) (FIBL-6);Mucin-like protein;Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan) (Adlican);Thioredoxin (Trx);Fucolectin-4;Fucolectin;Fucolectin;A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-);Immunoglobulin superfamily member 10 (IgSF10);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);Perlucin-like protein;Perlucin-like protein;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Mucin-like protein;CUB and peptidase domain-containing protein 1;CUB and peptidase domain-containing protein 1;CUB and peptidase domain-containing protein 1;Collagen alpha-4(VI) chain;Collagen alpha-1(XXIV) chain;Tachylectin-2 (Lectin L10c);Tachylectin-2 (Lectin L10c);Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)];Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK);Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK);Laminin subunit gamma-1;BPTI/Kunitz domain-containing protein;Mucin-like protein;Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Peroxidasin homolog pxn-2 (EC 1.11.2.-);Peroxidasin homolog pxn-2 (EC 1.11.2.-);Peroxidasin homolog pxn-2 (EC 1.11.2.-);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1);Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (ATP diphosphohydrolase) (ATP-DPH) (ATPDase) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (Nucleoside triphosphate diphosphohydrolase 1) (NTPDase1) (CD antigen CD39);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);DBH-like monooxygenase protein 2 homolog (EC 1.14.17.-);Hemagglutinin/amebocyte aggregation factor (18K-LAF);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Cilia- and flagella-associated protein 54;Reversion-inducing cysteine-rich protein with Kazal motifs;Putative gastrointestinal growth factor xP4 (TFF p4.1);DBH-like monooxygenase protein 1 (EC 1.14.17.-) (Monooxygenase X);DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X);CD63 antigen (CD antigen CD63);Hydramacin-1 (Hm-1);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Mucin-like protein;UPF0764 protein C16orf89 homolog;Fibrillin-1 [Cleaved into: Asprosin];Hemicentin-2;Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1);Accumulation-associated protein;Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid);Protein mesh;Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid);Cubilin (Intrinsic factor-cobalamin receptor);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);LWamide neuropeptides [Cleaved into: LWamide I; LWamide II; LWS];Collectin-11 (Collectin kidney protein 1) (CL-K1);Collagen alpha-3(VI) chain;Matrilin-2;Protein Wnt-2b-A (Wnt-2b) (XWnt-2b) (XWnt-2);Rootletin (Ciliary rootlet coiled-coil protein);Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5);Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III);Hatching enzyme 1.2 (EC 3.4.24.67) (Choriolysin H homolog 1) (High choriolytic enzyme 1 homolog) (zHCE-1);Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2);Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);Serotransferrin;Glucose-fructose oxidoreductase domain-containing protein 1 (EC 1.-.-.-);von Willebrand factor (vWF);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (Ribitol-5-phosphate transferase);Insulin-like growth factor-binding protein complex acid labile subunit (ALS);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Glutamine amidotransferase-like class 1 domain-containing protein 1 (Ferry endosomal RAB5 effector complex subunit 5) (Fy-5) (Parkinson disease 7 domain-containing protein 1);Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form];Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog);Netrin-1;LWamide neuropeptides [Cleaved into: LWamide I; Metamorphosin A (MMA) (LWamide II); LWamide III; LWamide IV; LWamide V; LWamide VI; LWamide VII; LWamide VIII; LWamide IX];Hemicentin-1 (Fibulin-6) (FIBL-6);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Bone morphogenetic protein 6 (BMP-6) (VG-1-related protein) (VG-1-R) (VGR-1);Repetitive proline-rich cell wall protein 2;Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34);Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34);Nephrocystin-3;Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Leucine-rich repeat-containing G-protein coupled receptor 6;Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III);Chloride intracellular channel protein 3 (Glutaredoxin-like oxidoreductase CLIC3) (EC 1.8.-.-);Thrombospondin-3;Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);Cell growth regulator with EF hand domain protein 1 (Cell growth regulatory gene 11 protein) (Hydrophobestin);Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Hemicentin-1 (Fibulin-6) (FIBL-6);Neuronal cell adhesion molecule (Nr-CAM) (Ankyrin-binding cell adhesion molecule NrCAM) (Neuronal surface protein Bravo) (rBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related);Hemicentin-1 (Fibulin-6) (FIBL-6);Mucin-like protein;Mucin-like protein;Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule 2) (Down syndrome cell adhesion molecule-like protein 1);Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1];Matrilin-2;Low-density lipoprotein receptor-related protein 6 (LRP-6);Low-density lipoprotein receptor-related protein 6 (LRP-6);Fucolectin-3;Mucin-5AC (MUC-5AC) (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM);6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44);Endo-1,4-beta-xylanase B (Xylanase B) (EC 3.2.1.8) (1,4-beta-D-xylan xylanohydrolase B);Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI);Follistatin-related protein 5 (Follistatin-like protein 5) (m-D/Bsp120I 1-2);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]"
"GO:0031045"	"dense core granule"	"Electron-dense organelle with a granular internal matrix; contains proteins destined to be secreted."	"27.778% (5/18)"	0.007834337	2.11	"Pocillopora_acuta_HIv2___RNAseq.g13403.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28815.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___RNAseq.g4031.t1c"	"Synaptotagmin-9 (Synaptotagmin IX) (SytIX);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI)"
"GO:0071944"	"cell periphery"	"The broad region around and including the plasma membrane of a cell, encompassing the cell cortex (inside the cell), the plasma membrane, and any external encapsulating structures."	"9.689% (262/2704)"	0.005273824	2.28	"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.18284_t;Pocillopora_acuta_HIv2___RNAseq.18788_t;Pocillopora_acuta_HIv2___RNAseq.25384_t;Pocillopora_acuta_HIv2___RNAseq.30415_t;Pocillopora_acuta_HIv2___RNAseq.6257_t;Pocillopora_acuta_HIv2___RNAseq.6942_t;Pocillopora_acuta_HIv2___RNAseq.7292_t;Pocillopora_acuta_HIv2___RNAseq.953_t;Pocillopora_acuta_HIv2___RNAseq.g10339.t1;Pocillopora_acuta_HIv2___RNAseq.g10475.t1;Pocillopora_acuta_HIv2___RNAseq.g10514.t1;Pocillopora_acuta_HIv2___RNAseq.g10927.t1;Pocillopora_acuta_HIv2___RNAseq.g10991.t1;Pocillopora_acuta_HIv2___RNAseq.g1102.t1;Pocillopora_acuta_HIv2___RNAseq.g11214.t1;Pocillopora_acuta_HIv2___RNAseq.g11345.t1;Pocillopora_acuta_HIv2___RNAseq.g11547.t1;Pocillopora_acuta_HIv2___RNAseq.g11548.t1;Pocillopora_acuta_HIv2___RNAseq.g11580.t1;Pocillopora_acuta_HIv2___RNAseq.g11747.t1;Pocillopora_acuta_HIv2___RNAseq.g11810.t1;Pocillopora_acuta_HIv2___RNAseq.g11916.t1;Pocillopora_acuta_HIv2___RNAseq.g1200.t1;Pocillopora_acuta_HIv2___RNAseq.g12115.t1;Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g12223.t1;Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g12293.t1;Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g12619.t1;Pocillopora_acuta_HIv2___RNAseq.g12682.t1;Pocillopora_acuta_HIv2___RNAseq.g12752.t1;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g13044.t1;Pocillopora_acuta_HIv2___RNAseq.g13056.t1;Pocillopora_acuta_HIv2___RNAseq.g13060.t1;Pocillopora_acuta_HIv2___RNAseq.g13403.t1;Pocillopora_acuta_HIv2___RNAseq.g13533.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g13576.t1;Pocillopora_acuta_HIv2___RNAseq.g13716.t1;Pocillopora_acuta_HIv2___RNAseq.g13796.t1;Pocillopora_acuta_HIv2___RNAseq.g13970.t2;Pocillopora_acuta_HIv2___RNAseq.g14013.t1a;Pocillopora_acuta_HIv2___RNAseq.g14348.t1;Pocillopora_acuta_HIv2___RNAseq.g14576.t1;Pocillopora_acuta_HIv2___RNAseq.g14869.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g15097.t1;Pocillopora_acuta_HIv2___RNAseq.g15838.t1;Pocillopora_acuta_HIv2___RNAseq.g16.t1;Pocillopora_acuta_HIv2___RNAseq.g16474.t1;Pocillopora_acuta_HIv2___RNAseq.g16699.t1;Pocillopora_acuta_HIv2___RNAseq.g17085.t1;Pocillopora_acuta_HIv2___RNAseq.g17089.t1;Pocillopora_acuta_HIv2___RNAseq.g17090.t1;Pocillopora_acuta_HIv2___RNAseq.g17093.t1;Pocillopora_acuta_HIv2___RNAseq.g17117.t1;Pocillopora_acuta_HIv2___RNAseq.g1720.t1;Pocillopora_acuta_HIv2___RNAseq.g17495.t1;Pocillopora_acuta_HIv2___RNAseq.g17559.t1;Pocillopora_acuta_HIv2___RNAseq.g17622.t1;Pocillopora_acuta_HIv2___RNAseq.g17965.t1;Pocillopora_acuta_HIv2___RNAseq.g18121.t1;Pocillopora_acuta_HIv2___RNAseq.g18123.t1;Pocillopora_acuta_HIv2___RNAseq.g18273.t1;Pocillopora_acuta_HIv2___RNAseq.g1841.t1;Pocillopora_acuta_HIv2___RNAseq.g18501.t1;Pocillopora_acuta_HIv2___RNAseq.g18951.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g19042.t1;Pocillopora_acuta_HIv2___RNAseq.g19043.t1;Pocillopora_acuta_HIv2___RNAseq.g19152.t1;Pocillopora_acuta_HIv2___RNAseq.g19312.t1;Pocillopora_acuta_HIv2___RNAseq.g19392.t1;Pocillopora_acuta_HIv2___RNAseq.g19428.t1;Pocillopora_acuta_HIv2___RNAseq.g19452.t1;Pocillopora_acuta_HIv2___RNAseq.g1971.t1;Pocillopora_acuta_HIv2___RNAseq.g19855.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g20170.t1;Pocillopora_acuta_HIv2___RNAseq.g20232.t1;Pocillopora_acuta_HIv2___RNAseq.g20413.t2;Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g20766.t1;Pocillopora_acuta_HIv2___RNAseq.g20846.t1;Pocillopora_acuta_HIv2___RNAseq.g20860.t1;Pocillopora_acuta_HIv2___RNAseq.g21021.t1;Pocillopora_acuta_HIv2___RNAseq.g21169.t1;Pocillopora_acuta_HIv2___RNAseq.g21265.t1;Pocillopora_acuta_HIv2___RNAseq.g21476.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g21637.t1;Pocillopora_acuta_HIv2___RNAseq.g22283.t1;Pocillopora_acuta_HIv2___RNAseq.g22296.t1;Pocillopora_acuta_HIv2___RNAseq.g2263.t1b;Pocillopora_acuta_HIv2___RNAseq.g22644.t1;Pocillopora_acuta_HIv2___RNAseq.g2273.t1;Pocillopora_acuta_HIv2___RNAseq.g22964.t1;Pocillopora_acuta_HIv2___RNAseq.g23004.t1;Pocillopora_acuta_HIv2___RNAseq.g23181.t1;Pocillopora_acuta_HIv2___RNAseq.g23361.t1;Pocillopora_acuta_HIv2___RNAseq.g23414.t1;Pocillopora_acuta_HIv2___RNAseq.g23883.t2;Pocillopora_acuta_HIv2___RNAseq.g24029.t1;Pocillopora_acuta_HIv2___RNAseq.g24097.t1;Pocillopora_acuta_HIv2___RNAseq.g24120.t1;Pocillopora_acuta_HIv2___RNAseq.g24660.t1;Pocillopora_acuta_HIv2___RNAseq.g24675.t1;Pocillopora_acuta_HIv2___RNAseq.g24761.t1;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___RNAseq.g25228.t1;Pocillopora_acuta_HIv2___RNAseq.g25317.t1;Pocillopora_acuta_HIv2___RNAseq.g25689.t1;Pocillopora_acuta_HIv2___RNAseq.g25691.t1;Pocillopora_acuta_HIv2___RNAseq.g25867.t1;Pocillopora_acuta_HIv2___RNAseq.g25934.t1;Pocillopora_acuta_HIv2___RNAseq.g26058.t1;Pocillopora_acuta_HIv2___RNAseq.g26118.t1;Pocillopora_acuta_HIv2___RNAseq.g26575.t1;Pocillopora_acuta_HIv2___RNAseq.g26586.t1;Pocillopora_acuta_HIv2___RNAseq.g26594.t2;Pocillopora_acuta_HIv2___RNAseq.g26596.t1;Pocillopora_acuta_HIv2___RNAseq.g26608.t1;Pocillopora_acuta_HIv2___RNAseq.g26672.t1;Pocillopora_acuta_HIv2___RNAseq.g26700.t1;Pocillopora_acuta_HIv2___RNAseq.g26783.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g27609.t1;Pocillopora_acuta_HIv2___RNAseq.g28025.t1;Pocillopora_acuta_HIv2___RNAseq.g2813.t4;Pocillopora_acuta_HIv2___RNAseq.g28202.t1;Pocillopora_acuta_HIv2___RNAseq.g28213.t1;Pocillopora_acuta_HIv2___RNAseq.g28227.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28398.t1;Pocillopora_acuta_HIv2___RNAseq.g28466.t1;Pocillopora_acuta_HIv2___RNAseq.g28678.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___RNAseq.g28815.t1;Pocillopora_acuta_HIv2___RNAseq.g28816.t1;Pocillopora_acuta_HIv2___RNAseq.g2915.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g29506.t1;Pocillopora_acuta_HIv2___RNAseq.g29617.t1;Pocillopora_acuta_HIv2___RNAseq.g29670.t2;Pocillopora_acuta_HIv2___RNAseq.g29841.t1;Pocillopora_acuta_HIv2___RNAseq.g3016.t1;Pocillopora_acuta_HIv2___RNAseq.g30214.t1;Pocillopora_acuta_HIv2___RNAseq.g30398.t1;Pocillopora_acuta_HIv2___RNAseq.g30425.t2;Pocillopora_acuta_HIv2___RNAseq.g30836.t1;Pocillopora_acuta_HIv2___RNAseq.g30992.t1;Pocillopora_acuta_HIv2___RNAseq.g30994.t1a;Pocillopora_acuta_HIv2___RNAseq.g3166.t1;Pocillopora_acuta_HIv2___RNAseq.g344.t1;Pocillopora_acuta_HIv2___RNAseq.g3532.t1;Pocillopora_acuta_HIv2___RNAseq.g3724.t1;Pocillopora_acuta_HIv2___RNAseq.g3743.t1;Pocillopora_acuta_HIv2___RNAseq.g3854.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___RNAseq.g4031.t1c;Pocillopora_acuta_HIv2___RNAseq.g4214.t1;Pocillopora_acuta_HIv2___RNAseq.g4369.t1;Pocillopora_acuta_HIv2___RNAseq.g4399.t2;Pocillopora_acuta_HIv2___RNAseq.g4757.t1;Pocillopora_acuta_HIv2___RNAseq.g4879.t1;Pocillopora_acuta_HIv2___RNAseq.g4919.t1;Pocillopora_acuta_HIv2___RNAseq.g5089.t1;Pocillopora_acuta_HIv2___RNAseq.g5252.t1;Pocillopora_acuta_HIv2___RNAseq.g5401.t1;Pocillopora_acuta_HIv2___RNAseq.g5755.t1;Pocillopora_acuta_HIv2___RNAseq.g584.t3a;Pocillopora_acuta_HIv2___RNAseq.g5859.t1;Pocillopora_acuta_HIv2___RNAseq.g626.t1;Pocillopora_acuta_HIv2___RNAseq.g6366.t1;Pocillopora_acuta_HIv2___RNAseq.g6379.t1;Pocillopora_acuta_HIv2___RNAseq.g6468.t1;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g687.t1;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g702.t1;Pocillopora_acuta_HIv2___RNAseq.g7100.t1;Pocillopora_acuta_HIv2___RNAseq.g7107.t1;Pocillopora_acuta_HIv2___RNAseq.g7215.t1;Pocillopora_acuta_HIv2___RNAseq.g7217.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1;Pocillopora_acuta_HIv2___RNAseq.g7553.t1;Pocillopora_acuta_HIv2___RNAseq.g7625.t1;Pocillopora_acuta_HIv2___RNAseq.g7626.t1;Pocillopora_acuta_HIv2___RNAseq.g7627.t1;Pocillopora_acuta_HIv2___RNAseq.g7628.t1;Pocillopora_acuta_HIv2___RNAseq.g7660.t2;Pocillopora_acuta_HIv2___RNAseq.g7678.t1;Pocillopora_acuta_HIv2___RNAseq.g7692.t1;Pocillopora_acuta_HIv2___RNAseq.g8004.t1;Pocillopora_acuta_HIv2___RNAseq.g8276.t1;Pocillopora_acuta_HIv2___RNAseq.g8520.t1;Pocillopora_acuta_HIv2___RNAseq.g8890.t1;Pocillopora_acuta_HIv2___RNAseq.g8913.t1;Pocillopora_acuta_HIv2___RNAseq.g8915.t1;Pocillopora_acuta_HIv2___RNAseq.g913.t2;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___RNAseq.g9609.t1;Pocillopora_acuta_HIv2___RNAseq.g9723.t1;Pocillopora_acuta_HIv2___RNAseq.g9789.t1;Pocillopora_acuta_HIv2___RNAseq.g9811.t1;Pocillopora_acuta_HIv2___RNAseq.g9955.t1;Pocillopora_acuta_HIv2___TS.g10198.t2;Pocillopora_acuta_HIv2___TS.g1253.t1;Pocillopora_acuta_HIv2___TS.g1376.t2;Pocillopora_acuta_HIv2___TS.g14552.t1;Pocillopora_acuta_HIv2___TS.g14960.t2;Pocillopora_acuta_HIv2___TS.g14962.t1;Pocillopora_acuta_HIv2___TS.g15134.t1;Pocillopora_acuta_HIv2___TS.g15668.t1;Pocillopora_acuta_HIv2___TS.g15672.t1;Pocillopora_acuta_HIv2___TS.g16172.t3;Pocillopora_acuta_HIv2___TS.g16482.t1;Pocillopora_acuta_HIv2___TS.g16484.t1;Pocillopora_acuta_HIv2___TS.g1731.t1;Pocillopora_acuta_HIv2___TS.g1768.t1;Pocillopora_acuta_HIv2___TS.g17699.t2;Pocillopora_acuta_HIv2___TS.g18947.t1;Pocillopora_acuta_HIv2___TS.g19097.t2;Pocillopora_acuta_HIv2___TS.g19790.t1;Pocillopora_acuta_HIv2___TS.g21128.t1;Pocillopora_acuta_HIv2___TS.g21857.t1;Pocillopora_acuta_HIv2___TS.g22105.t1;Pocillopora_acuta_HIv2___TS.g22622.t1;Pocillopora_acuta_HIv2___TS.g23115.t1;Pocillopora_acuta_HIv2___TS.g23175.t1;Pocillopora_acuta_HIv2___TS.g24662.t1;Pocillopora_acuta_HIv2___TS.g24807.t1;Pocillopora_acuta_HIv2___TS.g25792.t1c;Pocillopora_acuta_HIv2___TS.g26021.t1;Pocillopora_acuta_HIv2___TS.g27642.t1b;Pocillopora_acuta_HIv2___TS.g27807.t1;Pocillopora_acuta_HIv2___TS.g29407.t1;Pocillopora_acuta_HIv2___TS.g2952.t1;Pocillopora_acuta_HIv2___TS.g29618.t1;Pocillopora_acuta_HIv2___TS.g29621.t1;Pocillopora_acuta_HIv2___TS.g29848.t1;Pocillopora_acuta_HIv2___TS.g3024.t4;Pocillopora_acuta_HIv2___TS.g305.t1;Pocillopora_acuta_HIv2___TS.g3863.t1;Pocillopora_acuta_HIv2___TS.g4109.t3;Pocillopora_acuta_HIv2___TS.g4148.t1c;Pocillopora_acuta_HIv2___TS.g5171.t1;Pocillopora_acuta_HIv2___TS.g5415.t1;Pocillopora_acuta_HIv2___TS.g6578.t1;Pocillopora_acuta_HIv2___TS.g800.t1;Pocillopora_acuta_HIv2___TS.g8082.t1;Pocillopora_acuta_HIv2___TS.g9513.t1;Pocillopora_acuta_HIv2___TS.g9749.t1;Pocillopora_acuta_HIv2___TS.g9752.t3"	"Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);Putative ammonium transporter 3;Metabotropic glutamate receptor 3 (mGluR3);Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);Synaptotagmin-10 (Synaptotagmin X) (SytX);Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2);Kinesin-like protein KIF17 (MmKIF17);Glycine betaine/proline/choline/ectoine transporter VP1456;Adenosine receptor A2b;Myoferlin (Fer-1-like protein 3);DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1);Trimethylamine transporter (TMA transporter) (TMA-specific transporter);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor);Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I);Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Hemicentin-1 (Fibulin-6) (FIBL-6);Tetraspanin-33 (Tspan-33);Spectrin beta chain, erythrocytic (Beta-I spectrin);Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP);Adenosine receptor A2a;Ras-related protein Rab-3;Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho);Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);Universal stress protein A-like protein;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c);A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-);Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);Dopamine receptor 4;Low-density lipoprotein receptor-related protein 6 (LRP-6);Synaptotagmin-9 (Synaptotagmin IX) (SytIX);Protein sidekick-2;Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Tyrosine-protein kinase receptor torso (EC 2.7.10.1);Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B);Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein);Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (x-BETA1AR);Collagen alpha-4(VI) chain;G-protein coupled receptor GRL101;Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8);Laminin subunit gamma-1;Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor);Solute carrier family 12 member 2 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (NKCC1) (Na-K-CL symporter);Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Peroxidasin homolog pxn-2 (EC 1.11.2.-);Peroxidasin homolog pxn-2 (EC 1.11.2.-);Peroxidasin homolog pxn-2 (EC 1.11.2.-);GRB2-associated and regulator of MAPK protein 1 (GRB2-associated and regulator of MAPK1);Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1);Transmembrane protein 117;Bis(5'-adenosyl)-triphosphatase enpp4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4);TWiK family of potassium channels protein 7;Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln));Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor);Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2) (OsEFCAX2) (Protein NCX-like 2) (OsNCL2);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-);1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3) (PLC-delta-3);Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2);Tetraspanin-33 (Tspan-33);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G);Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G);High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2);Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-);Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2);Cortactin-binding protein 2 (CortBP2);Glycine betaine transporter 1;Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Tyrosine-protein kinase SRK2 (EC 2.7.10.2);Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1);Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (ATP diphosphohydrolase) (ATP-DPH) (ATPDase) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (Nucleoside triphosphate diphosphohydrolase 1) (NTPDase1) (CD antigen CD39);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);Hemagglutinin/amebocyte aggregation factor (18K-LAF);Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein homolog) (Protein primglo) (xPgo);Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2);Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Reversion-inducing cysteine-rich protein with Kazal motifs;CD63 antigen (CD antigen CD63);BTB/POZ domain-containing protein KCTD16;Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71);Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);Putative ammonium transporter 1;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25);Rho GTPase-activating protein 32 (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS);Myosin-VIIa (Protein crinkled);Fibroblast growth factor receptor (SpFGFR) (EC 2.7.10.1);5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B);VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1);Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA);Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];E3 ubiquitin-protein ligase RNF167 (EC 2.3.2.27) (RING finger protein 167);Cholesterol uptake protein 1;Annexin A6 (Annexin VI) (Annexin-6);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)];Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a);Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor);Ras-GEF domain-containing family member 1B;Arrestin domain-containing protein 3;Fibrillin-1 [Cleaved into: Asprosin];Rhodopsin, GQ-coupled (GQ-rhodopsin);Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein);Neogenin;Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9);Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8);Hemicentin-2;Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1);Neuronal acetylcholine receptor subunit alpha-7;Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3);Protein mesh;Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE);Cubilin (Intrinsic factor-cobalamin receptor);EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46);Neuronal acetylcholine receptor subunit beta-3;QRFP-like peptide receptor;Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein);Ephrin-B2a;Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Rhiminopeptidase A);Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);Synaptotagmin-1 (Synaptotagmin I) (SytI);Proton-coupled zinc antiporter SLC30A8 (Solute carrier family 30 member 8) (Zinc transporter 8) (ZnT-8);Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Protein YIPF4 (YIP1 family member 4);Septin-2;Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3);Matrilin-2;Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I);Storkhead-box protein 1;Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Rootletin (Ciliary rootlet coiled-coil protein);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3);Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2);Rhodopsin;Protein PLANT CADMIUM RESISTANCE 2 (AtPCR2);Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9);Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP);Protein sprouty homolog 2 (Spry-2);Tachykinin-like peptides receptor 86C (NKD);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI);Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2);Engulfment and cell motility protein 1 (Protein ced-12 homolog);Serotransferrin;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD);Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17);Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta);Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5);von Willebrand factor (vWF);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein);Adhesion G protein-coupled receptor L4;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133);Adenosine receptor A2a;Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (Ribitol-5-phosphate transferase);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Sperm receptor for egg jelly (suREJ);Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2);Insulin-like growth factor-binding protein complex acid labile subunit (ALS);Major facilitator superfamily domain-containing protein 12 (Protein grizzled);Major facilitator superfamily domain-containing protein 12 (Protein grizzled);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form];Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281);Toll-like receptor Tollo (Toll-like receptor 8);Toll-like receptor 2 (CD antigen CD282);Toll-like receptor 6 (CD antigen CD286);Diacylglycerol lipase-beta (DAGL-beta) (DAGLbeta) (DGL-beta) (EC 3.1.1.116) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta);Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2);Netrin-1;Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein);Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1);Hemicentin-1 (Fibulin-6) (FIBL-6);Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Sterile alpha motif domain-containing protein 12 (SAM domain-containing protein 12);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Monocarboxylate transporter 8 (MCT 8) (Solute carrier family 16 member 2);ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.-) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase);DIS3-like exonuclease 1 (EC 3.1.13.1);Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor);Protein dispatched;Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48);Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1);Sugar transporter SWEET1;Cadherin-23 (Otocadherin);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta);Mechanosensory protein 2;Myeloid differentiation primary response protein MyD88;Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7);Sodium channel protein 1 brain (Sodium channel protein I brain);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Leucine-rich repeat-containing G-protein coupled receptor 6;Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Neurexin-4 (Neurexin IV);Chloride intracellular channel protein 3 (Glutaredoxin-like oxidoreductase CLIC3) (EC 1.8.-.-);Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b);Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3);Major facilitator superfamily domain-containing protein 12;Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Hemicentin-1 (Fibulin-6) (FIBL-6);Neuronal cell adhesion molecule (Nr-CAM) (Ankyrin-binding cell adhesion molecule NrCAM) (Neuronal surface protein Bravo) (rBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related);Hemicentin-1 (Fibulin-6) (FIBL-6);Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule 2) (Down syndrome cell adhesion molecule-like protein 1);Putative potassium channel protein YugO;Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1];Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) (ATP-binding cassette transporter 12) (ATP-binding cassette 12);Matrilin-2;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133);Low-density lipoprotein receptor-related protein 6 (LRP-6);Low-density lipoprotein receptor-related protein 6 (LRP-6);Neutrophil cytosol factor 2 (NCF-2) (67 kDa neutrophil oxidase factor) (Neutrophil NADPH oxidase factor 2) (p67-phox);Protein unc-13 homolog C (Munc13-3);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5);Pejvakin (Autosomal recessive deafness type 59 protein);Mucin-5AC (MUC-5AC) (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM);Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);C-type lectin domain family 1 member B (C-type lectin-like receptor 2) (CLEC-2);Protocadherin-like protein;Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C);Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1);Carcinine transporter;Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]"
"GO:0014731"	"spectrin-associated cytoskeleton"	"The part of the cytoskeleton composed of spectrin, protein 4.1 and ankyrin. Spectrin-associated cytoskeleton is associated with the plasma membrane."	"38.462% (5/13)"	0.001597148	2.8	"Pocillopora_acuta_HIv2___RNAseq.g11810.t1;Pocillopora_acuta_HIv2___RNAseq.g20766.t1;Pocillopora_acuta_HIv2___RNAseq.g30836.t1;Pocillopora_acuta_HIv2___RNAseq.g5859.t1;Pocillopora_acuta_HIv2___TS.g18947.t1"	"Spectrin beta chain, erythrocytic (Beta-I spectrin);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)"
"GO:1902710"	"GABA receptor complex"	NA	"41.667% (5/12)"	0.001045164	2.98	"Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___TS.g305.t1"	"Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)"
"GO:0042734"	"presynaptic membrane"	"A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane."	"13.821% (17/123)"	0.007781624	2.11	"Pocillopora_acuta_HIv2___RNAseq.18788_t;Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g22296.t1;Pocillopora_acuta_HIv2___RNAseq.g26700.t1;Pocillopora_acuta_HIv2___RNAseq.g27609.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28398.t1;Pocillopora_acuta_HIv2___RNAseq.g28466.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___TS.g3024.t4"	"Metabotropic glutamate receptor 3 (mGluR3);Adenosine receptor A2a;Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);BTB/POZ domain-containing protein KCTD16;Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3);cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE);Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein);Ephrin-B2a;Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Protein unc-13 homolog C (Munc13-3)"
"GO:0043005"	"neuron projection"	"A prolongation or process extending from a nerve cell, e.g. an axon or dendrite."	"11.17% (85/761)"	0.004083659	2.39	"Pocillopora_acuta_HIv2___RNAseq.18788_t;Pocillopora_acuta_HIv2___RNAseq.5883_t;Pocillopora_acuta_HIv2___RNAseq.7292_t;Pocillopora_acuta_HIv2___RNAseq.g10158.t1;Pocillopora_acuta_HIv2___RNAseq.g11214.t1;Pocillopora_acuta_HIv2___RNAseq.g11916.t1;Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g12682.t1;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g13056.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g13970.t2;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g16050.t1;Pocillopora_acuta_HIv2___RNAseq.g17117.t1;Pocillopora_acuta_HIv2___RNAseq.g18756.t2;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g1971.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g20766.t1;Pocillopora_acuta_HIv2___RNAseq.g20846.t1;Pocillopora_acuta_HIv2___RNAseq.g21265.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g21831.t1;Pocillopora_acuta_HIv2___RNAseq.g22366.t1;Pocillopora_acuta_HIv2___RNAseq.g22644.t1;Pocillopora_acuta_HIv2___RNAseq.g24649.t1;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___RNAseq.g25228.t1;Pocillopora_acuta_HIv2___RNAseq.g25708.t1;Pocillopora_acuta_HIv2___RNAseq.g26575.t1;Pocillopora_acuta_HIv2___RNAseq.g26596.t1;Pocillopora_acuta_HIv2___RNAseq.g26672.t1;Pocillopora_acuta_HIv2___RNAseq.g26700.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g27609.t1;Pocillopora_acuta_HIv2___RNAseq.g28202.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28408.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___RNAseq.g28815.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g29670.t2;Pocillopora_acuta_HIv2___RNAseq.g299.t1;Pocillopora_acuta_HIv2___RNAseq.g3840.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___RNAseq.g4031.t1c;Pocillopora_acuta_HIv2___RNAseq.g4369.t1;Pocillopora_acuta_HIv2___RNAseq.g4399.t2;Pocillopora_acuta_HIv2___RNAseq.g4628.t1;Pocillopora_acuta_HIv2___RNAseq.g4919.t1;Pocillopora_acuta_HIv2___RNAseq.g5252.t1;Pocillopora_acuta_HIv2___RNAseq.g5711.t2;Pocillopora_acuta_HIv2___RNAseq.g5755.t1;Pocillopora_acuta_HIv2___RNAseq.g5859.t1;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1;Pocillopora_acuta_HIv2___RNAseq.g7550.t1;Pocillopora_acuta_HIv2___RNAseq.g763.t1;Pocillopora_acuta_HIv2___RNAseq.g8004.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___TS.g10198.t2;Pocillopora_acuta_HIv2___TS.g14552.t1;Pocillopora_acuta_HIv2___TS.g15134.t1;Pocillopora_acuta_HIv2___TS.g1768.t1;Pocillopora_acuta_HIv2___TS.g21128.t1;Pocillopora_acuta_HIv2___TS.g24662.t1;Pocillopora_acuta_HIv2___TS.g25792.t1c;Pocillopora_acuta_HIv2___TS.g26333.t1;Pocillopora_acuta_HIv2___TS.g28207.t1;Pocillopora_acuta_HIv2___TS.g28908.t1;Pocillopora_acuta_HIv2___TS.g3024.t4;Pocillopora_acuta_HIv2___TS.g305.t1;Pocillopora_acuta_HIv2___TS.g4109.t3;Pocillopora_acuta_HIv2___TS.g4312.t1;Pocillopora_acuta_HIv2___TS.g800.t1;Pocillopora_acuta_HIv2___TS.g9513.t1"	"Metabotropic glutamate receptor 3 (mGluR3);Calcium/calmodulin-dependent protein kinase type II subunit alpha (CaM kinase II subunit alpha) (CaMK-II subunit alpha) (EC 2.7.11.17);Kinesin-like protein KIF17 (MmKIF17);Cytoplasmic polyadenylation element-binding protein 2 (CPE-BP2) (CPE-binding protein 2) (mCPEB-2);Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I);Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10);Adenosine receptor A2a;Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c);Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Dopamine receptor 4;Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase) (Protein kinase RCK);Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1);Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Cortactin-binding protein 2 (CortBP2);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Kinesin-like protein KIF3C;Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X) (Lis-X);Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);Sacsin (DnaJ homolog subfamily C member 29);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)];Lipoxygenase homology domain-containing protein 1;Neogenin;Hemicentin-2;Neuronal acetylcholine receptor subunit alpha-7;Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE);Neuronal acetylcholine receptor subunit beta-3;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adaptor-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a);Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);Synaptotagmin-1 (Synaptotagmin I) (SytI);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3);Sacsin (DnaJ homolog subfamily C member 29);Advillin (p92);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2);Centrosomal protein of 290 kDa (Cep290) (Nephrocystin-6);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17);WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin);Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);MOB kinase activator 2 (Mob2 homolog) (Mps one binder kinase activator-like 2) (Ovary-specific MOB-like protein);Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22);Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48);Cadherin-23 (Otocadherin);Mechanosensory protein 2;Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b);Neuronal cell adhesion molecule (Nr-CAM) (Ankyrin-binding cell adhesion molecule NrCAM) (Neuronal surface protein Bravo) (rBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related);Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule 2) (Down syndrome cell adhesion molecule-like protein 1);Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1);D-serine dehydratase (EC 4.3.1.18) (D-serine deaminase);Complexin-1;Protein unc-13 homolog C (Munc13-3);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Pejvakin (Autosomal recessive deafness type 59 protein);Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22);Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C);Carcinine transporter"
"GO:0034702"	"monoatomic ion channel complex"	"A protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective monoatomic ion transport down its electrochemical gradient."	"13.014% (19/146)"	0.009632233	2.02	"Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g15097.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g23883.t2;Pocillopora_acuta_HIv2___RNAseq.g24029.t1;Pocillopora_acuta_HIv2___RNAseq.g26118.t1;Pocillopora_acuta_HIv2___RNAseq.g26672.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g28202.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g29670.t2;Pocillopora_acuta_HIv2___RNAseq.g5755.t1;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___TS.g16172.t3;Pocillopora_acuta_HIv2___TS.g19790.t1;Pocillopora_acuta_HIv2___TS.g21128.t1;Pocillopora_acuta_HIv2___TS.g21857.t1"	"Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1);Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA);Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein);Neuronal acetylcholine receptor subunit alpha-7;Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Neuronal acetylcholine receptor subunit beta-3;Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3);Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Sodium channel protein 1 brain (Sodium channel protein I brain);Chloride intracellular channel protein 3 (Glutaredoxin-like oxidoreductase CLIC3) (EC 1.8.-.-);Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b);Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3)"
"GO:0030673"	"axolemma"	"The portion of the plasma membrane surrounding an axon; it is a specialized trilaminar random mosaic of protein molecules floating within a fluid matrix of highly mobile phospholipid molecules, 7-8 nm in thickness."	"33.333% (6/18)"	0.001277473	2.89	"Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g20766.t1;Pocillopora_acuta_HIv2___RNAseq.g5859.t1"	"Adenosine receptor A2a;Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)"
"GO:0060170"	"ciliary membrane"	"The portion of the plasma membrane surrounding a cilium."	"17.544% (10/57)"	0.007529821	2.12	"Pocillopora_acuta_HIv2___RNAseq.g13970.t2;Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g21265.t1;Pocillopora_acuta_HIv2___RNAseq.g24120.t1;Pocillopora_acuta_HIv2___RNAseq.g29617.t1;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1"	"Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Septin-2;Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)"
"GO:0005886"	"plasma membrane"	"The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins."	"9.366% (229/2445)"	0.009120069	2.04	"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.18284_t;Pocillopora_acuta_HIv2___RNAseq.18788_t;Pocillopora_acuta_HIv2___RNAseq.25384_t;Pocillopora_acuta_HIv2___RNAseq.30415_t;Pocillopora_acuta_HIv2___RNAseq.6942_t;Pocillopora_acuta_HIv2___RNAseq.7292_t;Pocillopora_acuta_HIv2___RNAseq.953_t;Pocillopora_acuta_HIv2___RNAseq.g10339.t1;Pocillopora_acuta_HIv2___RNAseq.g10475.t1;Pocillopora_acuta_HIv2___RNAseq.g10514.t1;Pocillopora_acuta_HIv2___RNAseq.g10927.t1;Pocillopora_acuta_HIv2___RNAseq.g1102.t1;Pocillopora_acuta_HIv2___RNAseq.g11214.t1;Pocillopora_acuta_HIv2___RNAseq.g11547.t1;Pocillopora_acuta_HIv2___RNAseq.g11548.t1;Pocillopora_acuta_HIv2___RNAseq.g11580.t1;Pocillopora_acuta_HIv2___RNAseq.g11747.t1;Pocillopora_acuta_HIv2___RNAseq.g11810.t1;Pocillopora_acuta_HIv2___RNAseq.g11916.t1;Pocillopora_acuta_HIv2___RNAseq.g1200.t1;Pocillopora_acuta_HIv2___RNAseq.g12115.t1;Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g12223.t1;Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g12293.t1;Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g12619.t1;Pocillopora_acuta_HIv2___RNAseq.g12682.t1;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g13056.t1;Pocillopora_acuta_HIv2___RNAseq.g13060.t1;Pocillopora_acuta_HIv2___RNAseq.g13403.t1;Pocillopora_acuta_HIv2___RNAseq.g13533.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g13716.t1;Pocillopora_acuta_HIv2___RNAseq.g13970.t2;Pocillopora_acuta_HIv2___RNAseq.g14013.t1a;Pocillopora_acuta_HIv2___RNAseq.g14576.t1;Pocillopora_acuta_HIv2___RNAseq.g14869.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g15097.t1;Pocillopora_acuta_HIv2___RNAseq.g16.t1;Pocillopora_acuta_HIv2___RNAseq.g16474.t1;Pocillopora_acuta_HIv2___RNAseq.g16699.t1;Pocillopora_acuta_HIv2___RNAseq.g17093.t1;Pocillopora_acuta_HIv2___RNAseq.g17117.t1;Pocillopora_acuta_HIv2___RNAseq.g1720.t1;Pocillopora_acuta_HIv2___RNAseq.g17495.t1;Pocillopora_acuta_HIv2___RNAseq.g17559.t1;Pocillopora_acuta_HIv2___RNAseq.g17622.t1;Pocillopora_acuta_HIv2___RNAseq.g17965.t1;Pocillopora_acuta_HIv2___RNAseq.g18121.t1;Pocillopora_acuta_HIv2___RNAseq.g18123.t1;Pocillopora_acuta_HIv2___RNAseq.g18273.t1;Pocillopora_acuta_HIv2___RNAseq.g1841.t1;Pocillopora_acuta_HIv2___RNAseq.g18501.t1;Pocillopora_acuta_HIv2___RNAseq.g18951.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g19042.t1;Pocillopora_acuta_HIv2___RNAseq.g19043.t1;Pocillopora_acuta_HIv2___RNAseq.g19152.t1;Pocillopora_acuta_HIv2___RNAseq.g19392.t1;Pocillopora_acuta_HIv2___RNAseq.g19428.t1;Pocillopora_acuta_HIv2___RNAseq.g19452.t1;Pocillopora_acuta_HIv2___RNAseq.g19855.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g20170.t1;Pocillopora_acuta_HIv2___RNAseq.g20413.t2;Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g20766.t1;Pocillopora_acuta_HIv2___RNAseq.g21021.t1;Pocillopora_acuta_HIv2___RNAseq.g21169.t1;Pocillopora_acuta_HIv2___RNAseq.g21265.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g21637.t1;Pocillopora_acuta_HIv2___RNAseq.g22283.t1;Pocillopora_acuta_HIv2___RNAseq.g22296.t1;Pocillopora_acuta_HIv2___RNAseq.g2263.t1b;Pocillopora_acuta_HIv2___RNAseq.g22644.t1;Pocillopora_acuta_HIv2___RNAseq.g2273.t1;Pocillopora_acuta_HIv2___RNAseq.g22964.t1;Pocillopora_acuta_HIv2___RNAseq.g23004.t1;Pocillopora_acuta_HIv2___RNAseq.g23361.t1;Pocillopora_acuta_HIv2___RNAseq.g23414.t1;Pocillopora_acuta_HIv2___RNAseq.g23883.t2;Pocillopora_acuta_HIv2___RNAseq.g24029.t1;Pocillopora_acuta_HIv2___RNAseq.g24097.t1;Pocillopora_acuta_HIv2___RNAseq.g24120.t1;Pocillopora_acuta_HIv2___RNAseq.g24660.t1;Pocillopora_acuta_HIv2___RNAseq.g24675.t1;Pocillopora_acuta_HIv2___RNAseq.g24761.t1;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___RNAseq.g25228.t1;Pocillopora_acuta_HIv2___RNAseq.g25317.t1;Pocillopora_acuta_HIv2___RNAseq.g25689.t1;Pocillopora_acuta_HIv2___RNAseq.g25691.t1;Pocillopora_acuta_HIv2___RNAseq.g25867.t1;Pocillopora_acuta_HIv2___RNAseq.g26058.t1;Pocillopora_acuta_HIv2___RNAseq.g26118.t1;Pocillopora_acuta_HIv2___RNAseq.g26575.t1;Pocillopora_acuta_HIv2___RNAseq.g26586.t1;Pocillopora_acuta_HIv2___RNAseq.g26594.t2;Pocillopora_acuta_HIv2___RNAseq.g26596.t1;Pocillopora_acuta_HIv2___RNAseq.g26608.t1;Pocillopora_acuta_HIv2___RNAseq.g26672.t1;Pocillopora_acuta_HIv2___RNAseq.g26700.t1;Pocillopora_acuta_HIv2___RNAseq.g26783.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g27609.t1;Pocillopora_acuta_HIv2___RNAseq.g28025.t1;Pocillopora_acuta_HIv2___RNAseq.g2813.t4;Pocillopora_acuta_HIv2___RNAseq.g28202.t1;Pocillopora_acuta_HIv2___RNAseq.g28213.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28398.t1;Pocillopora_acuta_HIv2___RNAseq.g28466.t1;Pocillopora_acuta_HIv2___RNAseq.g28678.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___RNAseq.g28815.t1;Pocillopora_acuta_HIv2___RNAseq.g28816.t1;Pocillopora_acuta_HIv2___RNAseq.g2915.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g29506.t1;Pocillopora_acuta_HIv2___RNAseq.g29617.t1;Pocillopora_acuta_HIv2___RNAseq.g29670.t2;Pocillopora_acuta_HIv2___RNAseq.g3016.t1;Pocillopora_acuta_HIv2___RNAseq.g30398.t1;Pocillopora_acuta_HIv2___RNAseq.g30425.t2;Pocillopora_acuta_HIv2___RNAseq.g30836.t1;Pocillopora_acuta_HIv2___RNAseq.g30992.t1;Pocillopora_acuta_HIv2___RNAseq.g30994.t1a;Pocillopora_acuta_HIv2___RNAseq.g3166.t1;Pocillopora_acuta_HIv2___RNAseq.g344.t1;Pocillopora_acuta_HIv2___RNAseq.g3724.t1;Pocillopora_acuta_HIv2___RNAseq.g3743.t1;Pocillopora_acuta_HIv2___RNAseq.g3854.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___RNAseq.g4031.t1c;Pocillopora_acuta_HIv2___RNAseq.g4214.t1;Pocillopora_acuta_HIv2___RNAseq.g4369.t1;Pocillopora_acuta_HIv2___RNAseq.g4399.t2;Pocillopora_acuta_HIv2___RNAseq.g4757.t1;Pocillopora_acuta_HIv2___RNAseq.g4879.t1;Pocillopora_acuta_HIv2___RNAseq.g4919.t1;Pocillopora_acuta_HIv2___RNAseq.g5089.t1;Pocillopora_acuta_HIv2___RNAseq.g5252.t1;Pocillopora_acuta_HIv2___RNAseq.g5401.t1;Pocillopora_acuta_HIv2___RNAseq.g5755.t1;Pocillopora_acuta_HIv2___RNAseq.g5859.t1;Pocillopora_acuta_HIv2___RNAseq.g626.t1;Pocillopora_acuta_HIv2___RNAseq.g6366.t1;Pocillopora_acuta_HIv2___RNAseq.g6379.t1;Pocillopora_acuta_HIv2___RNAseq.g6468.t1;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g687.t1;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g702.t1;Pocillopora_acuta_HIv2___RNAseq.g7100.t1;Pocillopora_acuta_HIv2___RNAseq.g7107.t1;Pocillopora_acuta_HIv2___RNAseq.g7215.t1;Pocillopora_acuta_HIv2___RNAseq.g7217.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1;Pocillopora_acuta_HIv2___RNAseq.g7553.t1;Pocillopora_acuta_HIv2___RNAseq.g7625.t1;Pocillopora_acuta_HIv2___RNAseq.g7626.t1;Pocillopora_acuta_HIv2___RNAseq.g7627.t1;Pocillopora_acuta_HIv2___RNAseq.g7628.t1;Pocillopora_acuta_HIv2___RNAseq.g7660.t2;Pocillopora_acuta_HIv2___RNAseq.g7678.t1;Pocillopora_acuta_HIv2___RNAseq.g8004.t1;Pocillopora_acuta_HIv2___RNAseq.g8276.t1;Pocillopora_acuta_HIv2___RNAseq.g8520.t1;Pocillopora_acuta_HIv2___RNAseq.g8890.t1;Pocillopora_acuta_HIv2___RNAseq.g913.t2;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___RNAseq.g9609.t1;Pocillopora_acuta_HIv2___RNAseq.g9723.t1;Pocillopora_acuta_HIv2___RNAseq.g9789.t1;Pocillopora_acuta_HIv2___RNAseq.g9811.t1;Pocillopora_acuta_HIv2___RNAseq.g9955.t1;Pocillopora_acuta_HIv2___TS.g10198.t2;Pocillopora_acuta_HIv2___TS.g1253.t1;Pocillopora_acuta_HIv2___TS.g1376.t2;Pocillopora_acuta_HIv2___TS.g14552.t1;Pocillopora_acuta_HIv2___TS.g14960.t2;Pocillopora_acuta_HIv2___TS.g14962.t1;Pocillopora_acuta_HIv2___TS.g15134.t1;Pocillopora_acuta_HIv2___TS.g15668.t1;Pocillopora_acuta_HIv2___TS.g15672.t1;Pocillopora_acuta_HIv2___TS.g16172.t3;Pocillopora_acuta_HIv2___TS.g16482.t1;Pocillopora_acuta_HIv2___TS.g16484.t1;Pocillopora_acuta_HIv2___TS.g1768.t1;Pocillopora_acuta_HIv2___TS.g17699.t2;Pocillopora_acuta_HIv2___TS.g18947.t1;Pocillopora_acuta_HIv2___TS.g19097.t2;Pocillopora_acuta_HIv2___TS.g19790.t1;Pocillopora_acuta_HIv2___TS.g21128.t1;Pocillopora_acuta_HIv2___TS.g21857.t1;Pocillopora_acuta_HIv2___TS.g22105.t1;Pocillopora_acuta_HIv2___TS.g22622.t1;Pocillopora_acuta_HIv2___TS.g23175.t1;Pocillopora_acuta_HIv2___TS.g24662.t1;Pocillopora_acuta_HIv2___TS.g24807.t1;Pocillopora_acuta_HIv2___TS.g25792.t1c;Pocillopora_acuta_HIv2___TS.g26021.t1;Pocillopora_acuta_HIv2___TS.g27642.t1b;Pocillopora_acuta_HIv2___TS.g27807.t1;Pocillopora_acuta_HIv2___TS.g2952.t1;Pocillopora_acuta_HIv2___TS.g29618.t1;Pocillopora_acuta_HIv2___TS.g29621.t1;Pocillopora_acuta_HIv2___TS.g29848.t1;Pocillopora_acuta_HIv2___TS.g3024.t4;Pocillopora_acuta_HIv2___TS.g305.t1;Pocillopora_acuta_HIv2___TS.g3863.t1;Pocillopora_acuta_HIv2___TS.g4148.t1c;Pocillopora_acuta_HIv2___TS.g5171.t1;Pocillopora_acuta_HIv2___TS.g5415.t1;Pocillopora_acuta_HIv2___TS.g6578.t1;Pocillopora_acuta_HIv2___TS.g800.t1;Pocillopora_acuta_HIv2___TS.g8082.t1;Pocillopora_acuta_HIv2___TS.g9513.t1;Pocillopora_acuta_HIv2___TS.g9752.t3"	"Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);Putative ammonium transporter 3;Metabotropic glutamate receptor 3 (mGluR3);Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);Synaptotagmin-10 (Synaptotagmin X) (SytX);Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2);Kinesin-like protein KIF17 (MmKIF17);Glycine betaine/proline/choline/ectoine transporter VP1456;Adenosine receptor A2b;Myoferlin (Fer-1-like protein 3);DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1);Trimethylamine transporter (TMA transporter) (TMA-specific transporter);Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor);Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Hemicentin-1 (Fibulin-6) (FIBL-6);Tetraspanin-33 (Tspan-33);Spectrin beta chain, erythrocytic (Beta-I spectrin);Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP);Adenosine receptor A2a;Ras-related protein Rab-3;Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho);Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);Universal stress protein A-like protein;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c);Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Dopamine receptor 4;Low-density lipoprotein receptor-related protein 6 (LRP-6);Synaptotagmin-9 (Synaptotagmin IX) (SytIX);Protein sidekick-2;Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Tyrosine-protein kinase receptor torso (EC 2.7.10.1);Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein);Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (x-BETA1AR);G-protein coupled receptor GRL101;Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8);Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor);Solute carrier family 12 member 2 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (NKCC1) (Na-K-CL symporter);Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];GRB2-associated and regulator of MAPK protein 1 (GRB2-associated and regulator of MAPK1);Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1);Transmembrane protein 117;Bis(5'-adenosyl)-triphosphatase enpp4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4);TWiK family of potassium channels protein 7;Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln));Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor);Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2) (OsEFCAX2) (Protein NCX-like 2) (OsNCL2);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-);1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3) (PLC-delta-3);Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2);Tetraspanin-33 (Tspan-33);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G);Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G);High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter);1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2);Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-);Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2);Glycine betaine transporter 1;Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Tyrosine-protein kinase SRK2 (EC 2.7.10.2);Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (ATP diphosphohydrolase) (ATP-DPH) (ATPDase) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (Nucleoside triphosphate diphosphohydrolase 1) (NTPDase1) (CD antigen CD39);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein homolog) (Protein primglo) (xPgo);Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2);Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Reversion-inducing cysteine-rich protein with Kazal motifs;CD63 antigen (CD antigen CD63);BTB/POZ domain-containing protein KCTD16;Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71);Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);Putative ammonium transporter 1;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25);Rho GTPase-activating protein 32 (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS);Fibroblast growth factor receptor (SpFGFR) (EC 2.7.10.1);5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B);VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1);Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA);Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];E3 ubiquitin-protein ligase RNF167 (EC 2.3.2.27) (RING finger protein 167);Cholesterol uptake protein 1;Annexin A6 (Annexin VI) (Annexin-6);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)];Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a);Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor);Ras-GEF domain-containing family member 1B;Arrestin domain-containing protein 3;Rhodopsin, GQ-coupled (GQ-rhodopsin);Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein);Neogenin;Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9);Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8);Hemicentin-2;Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1);Neuronal acetylcholine receptor subunit alpha-7;Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3);Protein mesh;Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE);Cubilin (Intrinsic factor-cobalamin receptor);EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46);Neuronal acetylcholine receptor subunit beta-3;QRFP-like peptide receptor;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein);Ephrin-B2a;Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Rhiminopeptidase A);Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);Synaptotagmin-1 (Synaptotagmin I) (SytI);Proton-coupled zinc antiporter SLC30A8 (Solute carrier family 30 member 8) (Zinc transporter 8) (ZnT-8);Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Protein YIPF4 (YIP1 family member 4);Septin-2;Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3);Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Rootletin (Ciliary rootlet coiled-coil protein);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3);Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2);Rhodopsin;Protein PLANT CADMIUM RESISTANCE 2 (AtPCR2);Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP);Protein sprouty homolog 2 (Spry-2);Tachykinin-like peptides receptor 86C (NKD);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI);Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2);Engulfment and cell motility protein 1 (Protein ced-12 homolog);Serotransferrin;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD);Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17);Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta);Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein);Adhesion G protein-coupled receptor L4;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133);Adenosine receptor A2a;Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (Ribitol-5-phosphate transferase);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Sperm receptor for egg jelly (suREJ);Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2);Insulin-like growth factor-binding protein complex acid labile subunit (ALS);Major facilitator superfamily domain-containing protein 12 (Protein grizzled);Major facilitator superfamily domain-containing protein 12 (Protein grizzled);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form];Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281);Toll-like receptor Tollo (Toll-like receptor 8);Toll-like receptor 2 (CD antigen CD282);Toll-like receptor 6 (CD antigen CD286);Diacylglycerol lipase-beta (DAGL-beta) (DAGLbeta) (DGL-beta) (EC 3.1.1.116) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta);Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2);Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein);Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1);Hemicentin-1 (Fibulin-6) (FIBL-6);Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor);Sterile alpha motif domain-containing protein 12 (SAM domain-containing protein 12);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Monocarboxylate transporter 8 (MCT 8) (Solute carrier family 16 member 2);ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.-) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase);DIS3-like exonuclease 1 (EC 3.1.13.1);Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor);Protein dispatched;Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48);Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1);Sugar transporter SWEET1;Cadherin-23 (Otocadherin);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta);Mechanosensory protein 2;Myeloid differentiation primary response protein MyD88;Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7);Sodium channel protein 1 brain (Sodium channel protein I brain);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Leucine-rich repeat-containing G-protein coupled receptor 6;Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Neurexin-4 (Neurexin IV);Chloride intracellular channel protein 3 (Glutaredoxin-like oxidoreductase CLIC3) (EC 1.8.-.-);Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b);Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3);Major facilitator superfamily domain-containing protein 12;Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA);Hemicentin-1 (Fibulin-6) (FIBL-6);Neuronal cell adhesion molecule (Nr-CAM) (Ankyrin-binding cell adhesion molecule NrCAM) (Neuronal surface protein Bravo) (rBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related);Hemicentin-1 (Fibulin-6) (FIBL-6);Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule 2) (Down syndrome cell adhesion molecule-like protein 1);Putative potassium channel protein YugO;Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1];Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) (ATP-binding cassette transporter 12) (ATP-binding cassette 12);Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133);Low-density lipoprotein receptor-related protein 6 (LRP-6);Low-density lipoprotein receptor-related protein 6 (LRP-6);Neutrophil cytosol factor 2 (NCF-2) (67 kDa neutrophil oxidase factor) (Neutrophil NADPH oxidase factor 2) (p67-phox);Protein unc-13 homolog C (Munc13-3);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5);Mucin-5AC (MUC-5AC) (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM);Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);C-type lectin domain family 1 member B (C-type lectin-like receptor 2) (CLEC-2);Protocadherin-like protein;Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C);Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1);Carcinine transporter;Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]"
"GO:0034451"	"centriolar satellite"	"A small (70-100 nm) cytoplasmic granule that contains a number of centrosomal proteins; centriolar satellites traffic toward microtubule minus ends and are enriched near the centrosome."	"15.584% (12/77)"	0.009423893	2.03	"Pocillopora_acuta_HIv2___RNAseq.g10475.t1;Pocillopora_acuta_HIv2___RNAseq.g12614.t2;Pocillopora_acuta_HIv2___RNAseq.g13970.t2;Pocillopora_acuta_HIv2___RNAseq.g17678.t1;Pocillopora_acuta_HIv2___RNAseq.g17695.t1;Pocillopora_acuta_HIv2___RNAseq.g17728.t1;Pocillopora_acuta_HIv2___RNAseq.g17731.t1;Pocillopora_acuta_HIv2___RNAseq.g28991.t1;Pocillopora_acuta_HIv2___RNAseq.g4628.t1;Pocillopora_acuta_HIv2___RNAseq.g8965.t1;Pocillopora_acuta_HIv2___RNAseq.g9223.t1;Pocillopora_acuta_HIv2___TS.g13571.t1"	"Myoferlin (Fer-1-like protein 3);Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110);Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein);NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3);NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3);NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3);NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3);Centromere protein U (CENP-U) (MLF1-interacting protein);Centrosomal protein of 290 kDa (Cep290) (Nephrocystin-6);Coiled-coil domain-containing protein 18;Kelch-like ECH-associated protein 1;NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)"
"GO:0045211"	"postsynaptic membrane"	"A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane."	"17.751% (30/169)"	4.199017e-06	5.38	"Pocillopora_acuta_HIv2___RNAseq.18788_t;Pocillopora_acuta_HIv2___RNAseq.g11916.t1;Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g12293.t1;Pocillopora_acuta_HIv2___RNAseq.g12682.t1;Pocillopora_acuta_HIv2___RNAseq.g13056.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g16.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g20766.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g22296.t1;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___RNAseq.g25228.t1;Pocillopora_acuta_HIv2___RNAseq.g26575.t1;Pocillopora_acuta_HIv2___RNAseq.g26672.t1;Pocillopora_acuta_HIv2___RNAseq.g26700.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g28202.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___RNAseq.g4919.t1;Pocillopora_acuta_HIv2___RNAseq.g5252.t1;Pocillopora_acuta_HIv2___RNAseq.g5859.t1;Pocillopora_acuta_HIv2___RNAseq.g8004.t1;Pocillopora_acuta_HIv2___TS.g14960.t2;Pocillopora_acuta_HIv2___TS.g14962.t1;Pocillopora_acuta_HIv2___TS.g24662.t1;Pocillopora_acuta_HIv2___TS.g305.t1"	"Metabotropic glutamate receptor 3 (mGluR3);Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10);Adenosine receptor A2a;Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho);Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c);Dopamine receptor 4;Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);BTB/POZ domain-containing protein KCTD16;Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)];Neogenin;Neuronal acetylcholine receptor subunit alpha-7;Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Neuronal acetylcholine receptor subunit beta-3;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta);Neuronal cell adhesion molecule (Nr-CAM) (Ankyrin-binding cell adhesion molecule NrCAM) (Neuronal surface protein Bravo) (rBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)"
"GO:0032420"	"stereocilium"	"An actin-based protrusion from the apical surface of auditory and vestibular hair cells and of neuromast cells. These protrusions are supported by a bundle of cross-linked actin filaments (an actin cable), oriented such that the plus (barbed) ends are at the tip of the protrusion, capped by a tip complex which bridges to the plasma. Bundles of stereocilia act as mechanosensory organelles."	"24.39% (10/41)"	0.0005621055	3.25	"Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g20846.t1;Pocillopora_acuta_HIv2___RNAseq.g25708.t1;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1;Pocillopora_acuta_HIv2___TS.g10198.t2;Pocillopora_acuta_HIv2___TS.g14552.t1;Pocillopora_acuta_HIv2___TS.g4109.t3"	"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);Lipoxygenase homology domain-containing protein 1;Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48);Cadherin-23 (Otocadherin);Pejvakin (Autosomal recessive deafness type 59 protein)"
"GO:0033093"	"Weibel-Palade body"	"A large, elongated, rod-shaped secretory granule characteristic of vascular endothelial cells that contain a number of structurally and functionally distinct proteins, of which the best characterized are von Willebrand factor (VWF) and P-selectin. Weibel-Palade bodies are formed from the trans-Golgi network in a process that depends on VWF, which is densely packed in a highly organized manner, and on coat proteins that remain associated with the granules. Upon cell stimulation, regulated exocytosis releases the contained proteins to the cell surface, where they act in the recruitment of platelets and leukocytes and in inflammatory and vasoactive responses."	"50% (3/6)"	0.00653471	2.18	"Pocillopora_acuta_HIv2___RNAseq.g2263.t1b;Pocillopora_acuta_HIv2___RNAseq.g2813.t4;Pocillopora_acuta_HIv2___RNAseq.g584.t3a"	"Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71);EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46);von Willebrand factor (vWF)"
"GO:0009925"	"basal plasma membrane"	"The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis."	"12.5% (22/176)"	0.008955459	2.05	"Pocillopora_acuta_HIv2___RNAseq.g1200.t1;Pocillopora_acuta_HIv2___RNAseq.g12115.t1;Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g16474.t1;Pocillopora_acuta_HIv2___RNAseq.g19152.t1;Pocillopora_acuta_HIv2___RNAseq.g20766.t1;Pocillopora_acuta_HIv2___RNAseq.g24097.t1;Pocillopora_acuta_HIv2___RNAseq.g24120.t1;Pocillopora_acuta_HIv2___RNAseq.g25317.t1;Pocillopora_acuta_HIv2___RNAseq.g26594.t2;Pocillopora_acuta_HIv2___RNAseq.g30992.t1;Pocillopora_acuta_HIv2___RNAseq.g4919.t1;Pocillopora_acuta_HIv2___RNAseq.g5859.t1;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___TS.g10198.t2;Pocillopora_acuta_HIv2___TS.g16482.t1;Pocillopora_acuta_HIv2___TS.g16484.t1;Pocillopora_acuta_HIv2___TS.g1768.t1;Pocillopora_acuta_HIv2___TS.g27642.t1b"	"Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Solute carrier family 12 member 2 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (NKCC1) (Na-K-CL symporter);High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a);Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8);Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]"
"GO:0032579"	"apical lamina of hyaline layer"	"A fibrous network that is part of the hyalin layer extracellular matrix. The apical lamina is thought to be principally composed of the glycoproteins fibropellins. This matrix has been found in echinoderms."	"42.857% (6/14)"	0.0002660633	3.58	"Pocillopora_acuta_HIv2___RNAseq.g28227.t1;Pocillopora_acuta_HIv2___RNAseq.g8913.t1;Pocillopora_acuta_HIv2___RNAseq.g8915.t1;Pocillopora_acuta_HIv2___TS.g1731.t1;Pocillopora_acuta_HIv2___TS.g23115.t1;Pocillopora_acuta_HIv2___TS.g9749.t1"	"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)"
"GO:0008091"	"spectrin"	"Membrane associated dimeric protein (240 and 220 kDa) of erythrocytes. Forms a complex with ankyrin, actin and probably other components of the membrane cytoskeleton, so that there is a mesh of proteins underlying the plasma membrane, potentially restricting the lateral mobility of integral proteins."	"50% (3/6)"	0.00653471	2.18	"Pocillopora_acuta_HIv2___RNAseq.g11810.t1;Pocillopora_acuta_HIv2___RNAseq.g30836.t1;Pocillopora_acuta_HIv2___TS.g18947.t1"	"Spectrin beta chain, erythrocytic (Beta-I spectrin);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)"
